VALESSA MESIDOR: Open Payments
NPI 1972276285 · WANTAGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 12 payments from 4 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $184 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: ARISTADA, ABILIFY ASIMTUFII, AUSTEDO XR, ABILIFY MAINTENA, INGREZZA, UZEDY.
Industry payments across NY — which companies pay providers there.
